These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 38711620)

  • 1. Microphysiological systems as models for immunologically 'cold' tumors.
    Gaebler D; Hachey SJ; Hughes CCW
    Front Cell Dev Biol; 2024; 12():1389012. PubMed ID: 38711620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment.
    Kumar V; Varghese S
    Adv Healthc Mater; 2019 Feb; 8(4):e1801198. PubMed ID: 30516355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
    Ringquist R; Ghoshal D; Jain R; Roy K
    Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-chip recapitulation of the tumor microenvironment: A decade of progress.
    Giannitelli SM; Peluzzi V; Raniolo S; Roscilli G; Trombetta M; Mozetic P; Rainer A
    Biomaterials; 2024 Apr; 306():122482. PubMed ID: 38301325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
    Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
    Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy.
    Teer L; Yaddanapudi K; Chen J
    Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the immune microenvironment for ovarian cancer therapy.
    Blanc-Durand F; Clemence Wei Xian L; Tan DSP
    Front Immunol; 2023; 14():1328651. PubMed ID: 38164130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocktail strategy for 'cold' tumors therapy via active recruitment of CD8+ T cells and enhancing their function.
    Li X; Luo L; Jiang M; Zhu C; Shi Y; Zhang J; Qin B; Luo Z; Guo X; Lu Y; Shan X; Liu Y; Du Y; Ling P; You J
    J Control Release; 2021 Jun; 334():413-426. PubMed ID: 33964366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity.
    Seclì L; Infante L; Nocchi L; De Lucia M; Cotugno G; Leoni G; Micarelli E; Garzia I; Avalle L; Sdruscia G; Troise F; Allocca S; Romano G; Scarselli E; D'Alise AM
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors.
    Ouyang P; Wang L; Wu J; Tian Y; Chen C; Li D; Yao Z; Chen R; Xiang G; Gong J; Bao Z
    Front Immunol; 2024; 15():1344272. PubMed ID: 38545114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking the potential of the tumor microenvironment for cancer therapy.
    Tufail M
    Pathol Res Pract; 2023 Nov; 251():154846. PubMed ID: 37837860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
    Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.
    Jin Z; Sun X; Wang Y; Zhou C; Yang H; Zhou S
    Front Immunol; 2022; 13():1018903. PubMed ID: 36300110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment.
    Berger Fridman I; Kostas J; Gregus M; Ray S; Sullivan MR; Ivanov AR; Cohen S; Konry T
    Acta Biomater; 2021 Sep; 132():473-488. PubMed ID: 34153511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor microenvironment: shaping cancer progression and treatment response.
    Desai SA; Patel VP; Bhosle KP; Nagare SD; Thombare KC
    J Chemother; 2024 Jan; ():1-30. PubMed ID: 38179655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.
    El-Tanani M; Rabbani SA; Babiker R; Rangraze I; Kapre S; Palakurthi SS; Alnuqaydan AM; Aljabali AA; Rizzo M; El-Tanani Y; Tambuwala MM
    Cancer Lett; 2024 Jun; 591():216894. PubMed ID: 38626856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment signaling and therapeutics in cancer progression.
    Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
    Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.